Status:
COMPLETED
Evaluation of Novel Point of Care Coagulation System in Pregnant Women
Lead Sponsor:
University of Maryland, Baltimore
Collaborating Sponsors:
HemoSonics LLC
Conditions:
Hemorrhage
Coagulation Delay
Eligibility:
FEMALE
18-55 years
Brief Summary
In this study the investigators will evaluate a new point of care Quantra Hemostasis Analyzer system to assess coagulation rapidly with ease.
Detailed Description
Unexpected bleeding continues to be an issue that confronts anesthesiologists. Obstetric bleeding spearheads as the leading cause of maternal mortality and morbidity. One of the hurdles that clinician...
Eligibility Criteria
Inclusion
- Pregnant woman at 37-41 weeks gestation
Exclusion
- Hypertension
- Preeclampsia
- Gestational diabetes
- Preexisting coagulopathy
- History of deep vein thrombosis (DVT)
- Medications that impair coagulation
- History of pulmonary embolism or thrombosis
- Women in active labor receiving intravenous fluids or oxytocin
Key Trial Info
Start Date :
November 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT04301193
Start Date
November 1 2019
End Date
July 31 2020
Last Update
April 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maryland Baltimore
Baltimore, Maryland, United States, 21201